xbox
bind
protein
belong
cyclic
amp
respons
element
bind
proteinactiv
transcript
factor
crebatf
famili
transcript
regul
essenti
factor
control
termin
differenti
antibodyproduc
plasma
cell
impair
secret
immunoglobulin
observ
b
cell
also
play
major
role
regul
unfold
protein
respons
upr
trigger
endoplasm
reticulum
er
stress
two
isoform
found
cell
isoform
share
common
nterminu
contain
basicregion
leucin
zipper
bzip
domain
dimer
dna
bind
domin
isoform
er
stressfre
condit
activ
upr
induc
endoribonucleas
activ
inositol
requir
enzym
remov
nucleotid
open
read
frame
mrna
unconvent
splice
occur
cytoplasm
caus
frame
shift
amino
acid
lead
gener
replac
cterminu
strong
transactiv
domain
function
neg
regul
interact
transloc
cytoplasm
result
proteasomemedi
degrad
transcript
activ
upregul
express
er
chaperon
well
gene
involv
er
membran
synthesi
protein
secret
suggest
may
serv
ideal
target
cell
engin
enhanc
product
recombin
secretori
protein
inde
show
overexpress
increas
secretori
capac
cell
improv
product
recombin
protein
secretionlimit
mammalian
cell
furthermor
also
notic
nutrient
limit
environment
stress
cell
cultur
also
induc
upr
gener
rapid
growth
tumor
cell
coupl
inadequ
vascular
lead
shortag
oxygen
nutrient
hypoxia
glucos
depriv
within
solid
tumor
induc
upr
result
product
loss
sever
inhibit
tumor
growth
demonstr
essenti
surviv
factor
solid
tumor
also
repres
attract
target
develop
anticanc
drug
multipl
myeloma
mm
cancer
plasma
cell
blockad
product
use
compound
found
exhibit
signific
antimyeloma
activ
suggest
promis
therapeut
option
mm
target
infect
fifteen
differ
virus
report
induc
upr
host
cell
demonstr
regul
gene
express
two
oncovirus
human
tlymphotrop
viru
type
epsteinbarr
viru
ebv
caus
agent
adult
tcell
leukemia
lymphoma
transactiv
tax
shown
local
organel
associ
protein
secret
includ
er
golgi
complex
rais
possibl
infect
may
trigger
er
stress
upr
found
stimul
basal
taxactiv
transcript
addit
infect
induc
upr
upregul
express
establish
posit
feedback
loop
host
cell
nasopharyng
carcinoma
npc
epitheli
malign
close
associ
ebv
ebv
latent
membran
protein
welldocu
viral
oncoprotein
contribut
develop
npc
found
express
induc
upr
mediat
upregul
studi
reveal
role
regul
viral
transcript
suggest
may
also
serv
drug
target
develop
antivir
therapeut
local
transactiv
domain
within
cterminu
help
explain
transactiv
abil
previou
studi
identifi
histon
acetyltransferas
hat
factor
pcaf
specif
bind
protein
activ
interact
transactiv
domain
howev
molecular
mechan
transactiv
remain
larg
unknown
addit
factor
may
requir
regul
activ
discov
anoth
hat
gener
control
nonderepress
novel
bind
protein
although
share
ident
pcaf
associ
transactiv
domain
unexpectedli
demonstr
opposit
effect
inhibit
transcript
result
demonstr
novel
function
upr
modul
activ
previous
demonstr
pcaf
interact
transactiv
domain
activ
transcript
knockdown
pcaf
partial
block
express
target
gene
suggest
possibl
requir
factor
transcript
anoth
hat
share
ident
pcaf
amino
acid
sequenc
potenti
candid
transcript
regul
thu
examin
interact
two
isoform
cell
cotransfect
ie
express
plasmid
follow
coimmunoprecipit
coip
analysi
figur
antibodi
use
assay
recogn
isoform
found
immunoprecipit
complex
cell
cell
figur
reciproc
ip
use
antibodi
show
detect
immunoprecipit
complex
confirm
interact
figur
examin
interact
endogen
protein
without
upr
induct
upr
induc
tunicamycin
tm
use
trigger
upr
cell
sinc
protein
level
er
stressfre
cell
extrem
low
carri
ip
use
nuclear
extract
prepar
tmtreat
untreat
cell
increas
protein
level
detect
tmtreat
cell
figur
input
shown
figur
confirm
associ
endogen
protein
interestingli
decreas
interact
detect
upr
induc
figur
dimethyl
sulfoxid
dmso
vs
tm
treatment
narrow
specif
region
involv
bind
carri
domain
map
use
seri
hemagglutinin
ha
tag
truncat
figur
cell
cotransfect
vector
individu
truncat
plasmid
follow
ip
use
antibodi
ctermin
region
contain
transcript
activ
domain
found
associ
figur
neither
cterminu
domain
interact
figur
notic
heavi
chain
antibodi
also
recogn
secondari
antibodi
use
immunoblot
sinc
molecular
weight
heavi
chain
hatag
similar
kd
blot
could
reveal
presenc
immunoprecipit
confirm
interact
set
experi
anoth
western
blot
use
antibodi
recogn
common
domain
figur
blot
collect
result
demonstr
bind
transcript
activ
domain
locat
ctermin
region
domain
pcaf
associ
continu
map
domain
pcaf
requir
interact
ctermin
region
contain
acetyl
transferas
bromo
domain
found
bind
fig
b
aa
interact
detect
bromo
domain
delet
fig
b
aa
compar
pcaf
exhibit
differ
bind
mechan
n
ctermin
domain
pcaf
abl
associ
fig
aa
furthermor
delet
bromo
domain
pcaf
complet
abolish
interact
fig
aa
differ
bind
impli
pcaf
may
exhibit
distinct
effect
biolog
function
function
signific
interact
assess
transcript
assay
known
regul
transcript
cellular
gene
bip
ebv
oncogen
luciferas
report
express
luciferas
driven
bip
ebv
promot
ie
bipluc
respect
util
studi
cotransfect
cell
increas
luciferas
express
observ
bip
ebv
promot
figur
agreement
previou
studi
pcaf
activ
bip
transcript
figur
howev
pcaf
fail
stimul
activ
ebv
promot
figur
unexpectedli
significantli
decreas
luciferas
express
driven
either
bip
ebv
promot
figur
regul
transcript
target
gene
bind
upr
element
upr
locat
within
promot
next
determin
transcript
repress
target
gene
mediat
upr
well
address
issu
util
luciferas
report
vector
contain
five
upr
cellbas
assay
cell
increas
luciferas
express
observ
cotransfect
pcaf
activ
transcript
figur
contrast
overexpress
caus
inhibit
luc
express
driven
upr
figur
result
suggest
repress
transcript
upredepend
requir
express
endogen
target
gene
includ
bip
chop
edem
investig
quantit
revers
transcriptasepolymeras
chain
reaction
qrtpcr
overexpress
result
increas
mrna
level
bip
chop
edem
figur
express
target
gene
significantli
inhibit
coexpress
cell
figur
continu
examin
impact
ebv
oncogen
report
previous
overexpress
ebvinfect
cell
induc
express
coexpress
found
complet
inhibit
express
pcaf
partial
block
synthesi
figur
similar
result
also
observ
luc
report
assay
perform
earlier
figur
altern
approach
util
activ
express
treat
ebvinfect
cell
brefeldin
bfa
er
stress
induc
induct
well
observ
bfatreat
cell
figur
coexpress
complet
block
synthesi
effect
detect
pcaf
overexpress
cell
figur
knockdown
experi
carri
use
sirna
specif
target
first
confirm
effect
two
sirna
western
blot
figur
cell
cotransfect
luciferas
report
ie
express
plasmid
indic
sirna
figur
c
compar
transfect
empti
vector
enhanc
activ
promot
observ
express
cell
figur
c
first
two
transfect
sirna
specif
target
luciferas
use
report
respect
use
posit
control
caus
decreas
luciferas
express
figur
c
second
third
transfect
two
sirna
significantli
activ
luciferas
express
driven
promot
figur
c
agreement
overexpress
assay
result
demonstr
repressor
transcript
continu
examin
effect
knock
endogen
express
endogen
target
gene
use
effect
sirna
upregul
two
target
gene
bip
edem
observ
endogen
knock
figur
role
upr
investig
next
cell
treat
tm
protein
level
examin
increas
bip
protein
detect
hour
tm
treatment
confirm
success
induct
upr
figur
drop
protein
level
first
observ
hour
treatment
remain
low
hour
indic
express
neg
regul
upr
figur
decreas
level
pcaf
protein
also
detect
hour
posttreat
figur
involv
activ
upr
studi
examin
express
endogen
target
gene
includ
bip
chop
edem
use
qrtpcr
cell
transfect
mock
express
vector
follow
treatment
tm
elev
mrna
level
target
gene
detect
tm
incub
figur
ectop
express
significantli
inhibit
express
five
gene
figur
ident
set
assay
perform
use
thapsigargin
tg
upr
induc
similar
result
observ
figur
determin
effect
dna
bind
upr
chromatin
immunoprecipit
chip
assay
perform
examin
abund
target
gene
increas
bind
promot
bip
chop
edem
gene
detect
tm
treatment
figur
overexpress
significantli
inhibit
enrich
target
gene
figur
use
tg
altern
upr
induc
ident
set
chip
experi
carri
similar
inhibitori
effect
dna
bind
observ
figur
protein
acetyl
import
posttransl
modif
affect
larg
number
protein
signific
histon
acetyl
modif
chromatin
structur
gene
regul
well
establish
grow
number
nonhiston
protein
transcript
factor
identifi
acetyl
target
function
regul
acetyl
well
therefor
may
possibl
regul
activ
acetyl
ectop
express
found
acetyl
lysin
residu
unknown
endogen
hat
figur
long
exposur
candid
hat
could
acetyl
endogen
sinc
overexpress
result
acetyl
lysin
residu
figur
effect
acetyl
detect
pcaf
overexpress
figur
assess
import
acetyl
regul
activ
sitedirect
mutagenesi
perform
mutat
sixteen
lysin
residu
arginin
first
confirm
mutant
could
acetyl
figur
howev
mutant
still
could
bind
figur
report
assay
carri
next
result
show
still
maintain
transactiv
abil
activ
bip
ebv
promot
figur
interestingli
still
abl
suppress
activ
although
mutant
could
longer
acetyl
figur
conclud
acetyl
may
signific
effect
transactiv
activ
unstabl
protein
halflif
estim
around
min
notic
signific
increas
protein
level
cell
figur
e
investig
impact
stabil
use
cycloheximid
chx
inhibitor
protein
synthesi
mock
pcaftransfect
cell
level
protein
start
decreas
min
chx
treatment
almost
complet
diminish
posttreat
figur
contrast
higher
level
protein
observ
cell
level
remain
unchang
even
chx
treatment
figur
demonstr
overexpress
enhanc
stabil
observ
mutant
stabl
wildtyp
figur
addit
overexpress
fail
increas
stabil
mutant
protein
figur
shown
complex
transloc
nucleu
cytoplasm
lead
proteasomemedi
degrad
cotransfect
cell
hatag
indic
plasmid
ie
pcaf
figur
increas
protein
level
nuclear
detect
overexpress
cytoplasm
amount
remain
unchang
figur
nuclear
retent
reconfirm
immunofluoresc
figur
result
suggest
overexpress
prevent
protein
degrad
retain
within
nucleu
protein
ubiquitin
mainli
occur
lysin
residu
target
protein
result
proteasomemedi
protein
degrad
suspect
degrad
might
mediat
ubiquitinproteasom
pathway
protein
level
wildtyp
increas
treatment
proteasom
inhibitor
overexpress
partial
inhibit
proteasomemedi
degrad
figur
increas
protein
stabil
observ
mutant
could
longer
ubiquitin
figur
collect
data
suggest
stabil
protein
regul
ubiquitin
acetyl
lysin
residu
sinc
acetyl
show
littl
effect
activ
would
like
determin
requir
hat
activ
regul
gener
enzymat
inact
mutant
previous
describ
luciferas
report
assay
overexpress
wildtyp
led
increas
activ
htlv
promot
figur
wt
contrast
mutant
fail
activ
htlv
promot
confirm
loss
hat
activ
figur
mt
loss
hat
activ
disrupt
interact
demonstr
ip
analysi
figur
mt
cellbas
luciferas
assay
overexpress
hat
mutant
still
exhibit
strong
inhibit
transcript
includ
bip
ebv
figur
mt
continu
investig
impact
bind
target
gene
result
obtain
chipquantit
polymeras
chain
reaction
pcr
experi
show
overexpress
wildtyp
significantli
block
bind
promot
bip
chop
edem
gene
figur
wt
hat
mutant
also
exhibit
similar
pattern
inhibit
figur
mt
note
overexpress
wildtyp
hat
mutant
enhanc
protein
level
figur
even
increas
amount
protein
wt
hat
mtexpress
cell
transcript
still
significantli
inhibit
figur
result
suggest
prevent
recruit
target
gene
hat
activ
requir
inhibitori
mechan
domain
map
demonstr
pcaf
interact
bind
region
ie
ctermin
transactiv
domain
figur
e
thu
possibl
may
compet
pcaf
associ
impact
interact
examin
ip
decreas
bind
pcaf
detect
overexpress
cell
figur
investig
effect
recruit
pcaf
target
gene
agreement
previou
studi
pcaf
recruit
bip
chop
edem
gene
figur
howev
recruit
pcaf
significantli
inhibit
overexpress
figur
taken
togeth
conclud
disrupt
interact
inhibit
recruit
pcaf
target
gene
besid
role
gene
regul
hat
also
shown
involv
tumorigenesi
hat
divid
five
famili
includ
nacetyltransferas
gnat
myst
moz
relat
hat
hat
gener
transcript
factor
hat
nuclear
hormonerel
hat
pcaf
belong
gnat
famili
highli
homolog
protein
share
ident
amino
acid
sequenc
expect
protein
exhibit
ident
similar
biolog
function
protein
substrat
previous
show
pcaf
bind
stimul
activ
studi
identifi
anoth
bind
protein
demonstr
pcaf
bind
transactiv
domain
figur
observ
rais
possibl
may
behav
like
pcaf
function
activ
surpris
found
potent
inhibit
transcript
figur
overexpress
almost
complet
block
express
viral
oncoprotein
ebv
suggest
potenti
anticanc
activ
figur
e
block
bind
promot
target
gene
figur
furthermor
compet
pcaf
bind
interfer
recruit
pcaf
target
gene
figur
base
result
propos
molecular
mechan
posit
neg
regul
pcaf
respect
figur
involv
protein
complex
acetyltransferas
saga
upr
report
previous
yeast
strain
fail
induc
upr
indic
posit
essenti
role
upr
howev
note
yeast
one
type
hat
contain
pcaf
addit
yeast
aa
much
shorter
human
aa
contain
acetyl
transferas
bromo
domain
miss
ntermin
region
ie
pcaf
homolog
domain
present
vertebr
fig
addit
pcaf
homolog
domain
may
impact
activ
human
could
help
explain
function
differ
yeast
human
regul
upr
addit
shown
saga
complex
recruit
exampl
promot
upr
gene
role
regul
upr
gene
express
suggest
howev
none
studi
establish
direct
connect
saga
transcript
base
data
present
studi
possibl
saga
may
respons
activ
upr
gene
express
pcaf
examin
upr
treatment
tm
found
downregul
express
protein
figur
observ
suggest
limit
physiolog
role
pcaf
activ
regul
activ
target
gene
upr
contrast
uprinduc
repress
inhibitor
may
indic
potenti
role
upr
found
overexpress
significantli
inhibit
tm
tginduc
gene
express
bip
chop
edem
block
recruit
promot
figur
mainli
synthes
er
stress
howev
er
stressfre
condit
presenc
also
detect
certain
cell
line
interact
endogen
detect
normal
condit
figur
treatment
upr
induc
ie
tm
result
disrupt
endogen
protein
interact
although
increas
level
protein
observ
figur
result
suggest
physiolog
function
regul
express
target
gene
although
pcaf
bind
ctermin
region
two
protein
exhibit
differ
effect
acetyl
dna
bind
domain
studi
pcaf
demonstr
differ
region
pcaf
requir
associ
figur
observ
may
help
explain
function
differ
pcaf
overexpress
result
acetyl
lysin
residu
figur
acetyl
lead
enhanc
protein
stabil
chang
subcellular
distribut
figur
c
short
halflif
stabl
protein
degrad
proteasomemedi
pathway
possibl
may
ubiquitin
lysin
residu
unknown
ubiquitin
ligas
ubiquitin
may
later
direct
proteasom
degrad
may
acetyl
lysin
residu
also
ubiquitin
therefor
protect
ubiquitin
degrad
agreement
hypothesi
increas
protein
stabil
detect
also
resist
proteasomemedi
protein
degrad
figur
detect
acetyl
observ
pcaf
overexpress
figur
expect
pcaf
effect
either
protein
stabil
nuclearcytoplasm
distribut
figur
c
perform
chip
assay
demonstr
overexpress
consist
inhibit
bind
target
gene
vivo
figur
contrari
pcaf
show
littl
activ
effect
dna
bind
figur
although
pcaf
share
high
ident
bind
domain
figur
e
two
protein
certainli
interact
differ
fashion
possibl
support
domain
map
pcaf
found
associ
cterminu
n
ctermin
region
pcaf
could
bind
figur
futur
investig
requir
reveal
structur
differ
complex
provid
molecular
insight
function
effect
caus
pcaf
protein
acetyl
import
posttransl
modif
affect
larg
number
histon
nonhiston
protein
signific
histon
acetyl
modif
chromatin
structur
gene
transcript
regul
well
recogn
grow
number
nonhiston
protein
identifi
acetyl
target
interestingli
mani
nonhiston
protein
nuclear
cmyc
hypoxiainduc
target
acetyl
relev
tumorigenesi
cancer
cell
prolifer
acetyl
stimul
inhibit
transactiv
abil
transcript
factor
affect
dna
bind
activ
report
acetyl
transcript
factor
swisnf
reduc
dna
bind
abil
chip
analysi
present
studi
demonstr
also
inhibit
dna
bind
vivo
figur
surprisingli
hat
activ
requir
inactiv
figur
interest
find
suggest
may
inhibit
transactiv
simpli
proteinprotein
interact
subcellular
local
transcript
factor
also
regul
acetyl
acetyl
hepatocyt
nuclear
crebbind
protein
found
crucial
nuclear
retent
also
observ
exhibit
similar
effect
caus
accumul
nucleu
figur
known
form
heterodim
transloc
nucleu
cytoplasm
result
proteasomedepend
degrad
therefor
acetyl
retain
within
nucleu
stabil
protein
figur
involv
cancer
report
sever
group
anticanc
approach
propos
target
rapid
growth
tumor
cell
associ
hypoxia
glucos
depriv
due
inadequ
vascular
solid
tumor
pathophysiolog
condit
trigger
upr
induc
activ
help
cancer
cell
surviv
harsh
cytotox
microenviron
remov
nucleotid
open
read
frame
mrna
requir
product
upon
activ
upr
blockad
synthesi
use
compound
includ
toyocamycin
demonstr
promis
therapeut
option
mm
tripleneg
breast
cancer
tnbc
form
breast
cancer
express
oestrogen
receptor
progesteron
receptor
tnbc
highli
aggress
limit
treatment
option
sinc
chemotherapi
target
one
three
receptor
recent
studi
indic
highlevel
express
tnbc
knockdown
effect
block
tnbc
cell
growth
invas
studi
identifi
inhibitor
exhibit
potenti
anticanc
activ
block
express
oncogen
ebv
regul
futur
investig
carri
determin
anticanc
activ
mm
tnbc
infect
variou
virus
also
trigger
upr
host
cell
virus
jev
dv
use
er
host
cell
primari
site
glycoprotein
synthesi
genom
rna
replic
viru
particl
matur
thu
trigger
er
stress
well
upr
case
viral
protein
hcmv
tax
traffic
er
golgi
complex
host
cell
induc
upr
mani
case
virus
modul
upr
attenu
antivir
defens
host
cell
facilit
viral
gene
express
replic
demonstr
requir
gene
regul
ebv
besid
studi
group
shown
involv
reactiv
kshv
replic
iv
suggest
may
serv
potenti
target
develop
therapeut
virus
mani
antivir
drug
target
viral
protein
howev
due
high
mutat
rate
virus
treatment
drug
categori
result
select
resist
viral
strain
sinc
cellular
factor
less
like
resist
strain
aris
use
antivir
therapeut
cell
obtain
american
type
cultur
collect
ebvinfect
cell
describ
previou
studi
sirna
sirna
firefli
luciferas
purchas
qiagen
human
express
plasmid
firefli
luciferas
report
plasmid
describ
previous
express
plasmid
human
pcaf
access
access
obtain
open
biosystem
gener
green
fluoresc
protein
gfp
tag
pcaf
truncat
pcaf
cdna
use
templat
pcr
amplif
amplifi
dna
fragment
subclon
vector
clontech
mutant
plasmid
gener
sitedirect
mutagenesi
stratagen
replac
sixteen
lysin
residu
arginin
hatinact
mutant
gener
previous
describ
plasmid
contain
seri
hatag
delet
gener
gift
dr
hider
yoshida
firefli
luciferas
report
plasmid
htlvluc
bipluc
protein
respons
elementluc
ie
kindli
provid
dr
arnold
rabson
dr
kazutoshi
mori
respect
tm
sigma
tg
sigma
calbiochem
bfa
sigma
dissolv
dmso
induc
upr
cell
treat
bfa
hour
tm
hour
nm
tg
hour
transient
transfect
dna
plasmid
cell
perform
use
fugen
roch
accord
manufactur
instruct
perform
cellbas
overexpress
assay
cell
grown
confluenc
plate
cotransfect
luciferas
report
express
plasmid
lipofectamin
reagent
invitrogen
util
cotransfect
cell
dna
plasmid
sirna
cellbas
knockdown
experi
firefli
luciferas
activ
measur
hour
posttransfect
use
brightglo
assay
system
promega
activ
determin
use
infinit
multipl
reader
tecan
cell
transient
cotransfect
indic
express
plasmid
cell
lysat
prepar
two
day
posttransfect
coip
get
high
level
ectop
express
highli
transfect
deriv
chosen
coip
studi
ip
kit
purchas
roch
coip
perform
accord
manufactur
instruct
immunoprecipit
complex
analyz
western
blot
western
blot
carri
accord
standard
protocol
horseradish
peroxidaseconjug
secondari
antibodi
purchas
pierc
antibodi
incub
blot
wash
incub
supersign
west
pico
substrat
pierc
chemiluminesc
signal
detect
use
xray
film
roch
film
scan
protein
band
quantifi
densitomet
biorad
antibodi
use
studi
includ
antiebv
kerafast
antibip
antipcaf
antilamin
b
santa
cruz
biotechnolog
antiacetyl
lysin
abcam
antiha
sigma
antiactin
millipor
antiglyceraldehyd
dehydrogenas
gapdh
cell
signal
total
rna
express
vectortransfect
tmtgtreat
cell
isol
use
rneasi
mini
kit
qiagen
one
microgram
total
rna
convert
complementari
dna
cdna
use
impromtmii
revers
transcript
system
promega
specif
cdna
amplifi
use
sybr
green
pcr
master
mix
appli
biosystem
primer
pair
use
studi
includ
bip
chop
edem
gapdh
gapdh
use
control
normal
cdna
input
amplif
detect
cdna
perform
use
abi
prism
thermalcycl
appli
biosystem
chip
assay
carri
use
ez
chip
kit
millipor
accord
manufactur
protocol
modif
cell
treat
tm
tg
prior
crosslink
dna
fragment
around
bp
achiev
sonic
microson
ultrason
cell
disruptor
misonix
ip
indic
antibodi
ie
antipcaf
antibodi
ad
shear
chromatin
individu
incub
overnight
dnaproteinantibodi
complex
pull
protein
g
agaros
dna
complex
purifi
use
qiaquick
pcr
purif
kit
qiagen
quantitativepcr
perform
determin
rel
amount
dna
immunoprecipit
antipcaf
antibodi
presenc
tm
tg
primer
pair
use
amplifi
promot
region
bip
chop
edem
gene
includ
bip
chop
edem
epitect
chip
qpcr
primer
qiagen
cell
treat
dmso
serv
neg
control
overexpress
cell
cotransfect
indic
express
vector
two
day
prior
crosslink
follow
chipquantitativepcr
describ
earlier
data
shown
includ
luciferas
assay
qrtpcr
quantit
chip
analyz
use
student
test
signific
level
p
